Luo, Fan
Lu, Fei-Teng http://orcid.org/0000-0002-4782-9436
Qiu, Miao-Zhen http://orcid.org/0000-0002-4774-6235
Zhou, Ting
Ma, Wen-Juan
Luo, Min
Zeng, Kang-Mei
Luo, Qiu-Yun
Pan, Wen-Tao
Zhang, Lin
Xia, Zeng-Fei
Zhang, Zhong-Han
Cao, Jia-Xin
Zhao, Hong-Yun
Zhang, Li
Yang, Da-Jun
Funding for this research was provided by:
National Natural Science Foundation of China (82073377, 81772587, 82003268, 82073396, 81872201)
Natural Science Foundation of Guangdong Province (2018A030310260, 2018A0303130243, 2020A1515011464)
Medical Science and Technology Foundation of Guangdong Province (2017B020227001)
Chinese Society of Clinical Oncology (Y-JS2019-046)
Article History
Received: 1 March 2021
Revised: 15 July 2021
Accepted: 19 July 2021
First Online: 5 August 2021
Competing interests
: Da-Jun Yang has ownership interest (including patents) in Ascentage Pharma Group Corp. Limited. Wen-Tao Pan is an employee of Ascentage Pharma Group Corp. Limited. No potential conflicts of interest were disclosed by the other authors.
: The Guangdong Provincial Animal Care and Use Committee approved all the in vivo experiments.